A quantitative multimodal metabolomic assay for colorectal cancer

Early diagnosis of colorectal cancer (CRC) simplifies treatment and improves treatment outcomes. We previously described a diagnostic metabolomic biomarker derived from semi-quantitative gas chromatographymass spectrometry.